Literature DB >> 28752469

8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers.

Yun Shin Chun1, Timothy M Pawlik2, Jean-Nicolas Vauthey3.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28752469     DOI: 10.1245/s10434-017-6025-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  160 in total

Review 1.  Critical appraisal of Chinese 2017 guideline on the management of hepatocellular carcinoma.

Authors:  Di-Yang Xie; Zheng-Gang Ren; Jian Zhou; Jia Fan; Qiang Gao
Journal:  Hepatobiliary Surg Nutr       Date:  2017-12       Impact factor: 7.293

2.  Impact of Neoadjuvant Therapy on Survival Following Margin-Positive Resection for Pancreatic Cancer.

Authors:  Asmita Chopra; Mazen Zenati; Melissa E Hogg; Herbert J Zeh; David L Bartlett; Nathan Bahary; Amer H Zureikat; Joal D Beane
Journal:  Ann Surg Oncol       Date:  2021-05-23       Impact factor: 5.344

3.  Validation of the prognostic performance in various nodal staging systems for gallbladder cancer: results of a multicenter study.

Authors:  Woohyung Lee; Chi-Young Jeong; Young Hoon Kim; Young Hoon Roh; Myung Hee Yoon; Hyung Il Seo; Jeong-Ik Park; Bo-Hyun Jung; Dong Hoon Shin; Young Il Choi; Je Ho Ryu; Kwang Ho Yang; Chang Soo Choi; Yo-Han Park; Yang Won Nah; Soon-Chan Hong
Journal:  Langenbecks Arch Surg       Date:  2019-08-14       Impact factor: 3.445

4.  Role of Adjuvant Multimodality Therapy After Curative-Intent Resection of Ampullary Carcinoma.

Authors:  Brett L Ecker; Charles M Vollmer; Stephen W Behrman; Valentina Allegrini; John Aversa; Chad G Ball; Courtney E Barrows; Adam C Berger; Martha N Cagigas; John D Christein; Elijah Dixon; William E Fisher; Mollie Freedman-Weiss; Francisco Guzman-Pruneda; Robert H Hollis; Michael G House; Tara S Kent; Stacy J Kowalsky; Giuseppe Malleo; Ronald R Salem; Roberto Salvia; Carl R Schmidt; Thomas F Seykora; Richard Zheng; Amer H Zureikat; Paxton V Dickson
Journal:  JAMA Surg       Date:  2019-08-01       Impact factor: 14.766

Review 5.  Multimodality Management of Localized Biliary Cancer.

Authors:  Nadia Ashai; Preethi Prasad; Lakshmi Rajdev
Journal:  Curr Treat Options Oncol       Date:  2019-05-29

6.  SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivo.

Authors:  Chi-Neu Tsai; Shu-Chuan Yu; Chao-Wei Lee; Jong-Hwei Su Pang; Chun-Hsin Wu; Sey-En Lin; Yi-Hsiu Chung; Chia-Lung Tsai; Sen-Yung Hsieh; Ming-Chin Yu
Journal:  Oncogene       Date:  2020-05-13       Impact factor: 9.867

7.  A New Scoring Method for Personalized Prognostic Prediction in Patients with Combined Hepatocellular and Cholangiocarcinoma After Surgery.

Authors:  Feng Zhang; Keshu Hu; Bei Tang; Mengxin Tian; Shenxin Lu; Jia Yuan; Miao Li; Rongxin Chen; Zhenggang Ren; Yinghong Shi; Xin Yin
Journal:  J Gastrointest Surg       Date:  2020-04-29       Impact factor: 3.452

8.  International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer.

Authors:  Stijn van Roessel; Gyulnara G Kasumova; Joanne Verheij; Robert M Najarian; Laura Maggino; Matteo de Pastena; Giuseppe Malleo; Giovanni Marchegiani; Roberto Salvia; Sing Chau Ng; Susanna W de Geus; Sanne Lof; Francesco Giovinazzo; Jacob L van Dam; Tara S Kent; Olivier R Busch; Casper H van Eijck; Bas Groot Koerkamp; Mohammed Abu Hilal; Claudio Bassi; Jennifer F Tseng; Marc G Besselink
Journal:  JAMA Surg       Date:  2018-12-19       Impact factor: 14.766

9.  Clinical observation of octreotide combined with diclofenac sodium in preventing ERCP-related pancreatitis.

Authors:  Xian Zhou; Jianwu Long; Hui Wang; Shijie Yi; Jun Zhao
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  Overexpression of long non-coding RNA cancer susceptibility 11 is involved in the development of chemoresistance to carboplatin in hepatocellular carcinoma.

Authors:  Haidong Liu; Tao Liu; Yong Zhou; Xinwen Song; Rendong Wei
Journal:  Oncol Lett       Date:  2020-01-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.